SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-018784
Filing Date
2023-05-24
Accepted
2023-05-24 08:00:18
Documents
12
Period of Report
2023-05-18
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35189
  Complete submission text file 0001493152-23-018784.txt   210038

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE envb-20230518.xsd EX-101.SCH 2956
3 XBRL LABEL FILE envb-20230518_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE envb-20230518_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3744
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 23950643
SIC: 2834 Pharmaceutical Preparations